This poster summarizes results from a data cut in December 2020 for an ongoing Phase 1, first in human, open-label, dose escalation and expansion study of MT-5111 in subjects with HER2+ solid tumors.
VoiceThread Recording Submission Deadline (for those accepted for Virtual and In-person Posters): Jan. 26, 2026 at 5 p.m. Upon abstract acceptance, all posters must be uploaded and recorded on ...
Exhibits consist of a visual display of a single work or a collection of work by one or more students (i.e. paintings, drawings, prints, posters, photography, sculpture, ceramics, installation, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback